Open Access

In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus

  • Authors:
    • Ahmed Hassan Arbab
    • Mohammad Khalid Parvez
    • Mohammed Salem Al‑Dosari
    • Adnan Jathlan Al‑Rehaily
  • View Affiliations

  • Published online on: May 31, 2017     https://doi.org/10.3892/etm.2017.4530
  • Pages: 626-634
  • Copyright: © Arbab et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Currently, >35 Saudi Arabian medicinal plants are traditionally used for various liver disorders without a scientific rationale. This is the first experimental evaluation of the anti‑hepatitis B virus (HBV) potential of the total ethanolic and sequential organic extracts of 60 candidate medicinal plants. The extracts were tested for toxicity on HepG2.2.15 cells and cytotoxicity concentration (CC50) values were determined. The extracts were further investigated on HepG2.2.15 cells for anti‑HBV activities by analyzing the inhibition of HBsAg and HBeAg production in the culture supernatants, and their half maximal inhibitory concentration (IC50) and therapeutic index (TI) values were determined. Of the screened plants, Guiera senegalensis (dichloromethane extract, IC50=10.65), Pulicaria crispa (ethyl acetate extract, IC50=14.45), Coccinea grandis (total ethanol extract, IC50=31.57), Fumaria parviflora (hexane extract, IC50=35.44), Capparis decidua (aqueous extract, IC50=66.82), Corallocarpus epigeus (total ethanol extract, IC50=71.9), Indigofera caerulea (methanol extract, IC50=73.21), Abutilon figarianum (dichloromethane extract, IC50=99.76) and Acacia oerfota (total ethanol extract, IC50=101.46) demonstrated novel anti‑HBV activities in a time‑ and dose‑dependent manner. Further qualitative phytochemical analysis of the active extracts revealed the presence of alkaloids, tannins, flavonoids and saponins, which are attributed to antiviral efficacies. In conclusion, P. crispa, G. senegalensis and F. parviflora had the most promising anti‑HBV potentials, including those of C. decidua, C. epigeus, A. figarianum, A. oerfota and I. caerulea with marked activities. However, a detailed phytochemical study of these extracts is essential to isolate the active principle(s) responsible for their novel anti-HBV potential.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Arbab AH, Parvez MK, Al‑Dosari MS and Al‑Rehaily AJ: In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Exp Ther Med 14: 626-634, 2017.
APA
Arbab, A.H., Parvez, M.K., Al‑Dosari, M.S., & Al‑Rehaily, A.J. (2017). In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Experimental and Therapeutic Medicine, 14, 626-634. https://doi.org/10.3892/etm.2017.4530
MLA
Arbab, A. H., Parvez, M. K., Al‑Dosari, M. S., Al‑Rehaily, A. J."In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus". Experimental and Therapeutic Medicine 14.1 (2017): 626-634.
Chicago
Arbab, A. H., Parvez, M. K., Al‑Dosari, M. S., Al‑Rehaily, A. J."In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus". Experimental and Therapeutic Medicine 14, no. 1 (2017): 626-634. https://doi.org/10.3892/etm.2017.4530